Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (299)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
23
2023
449
3.650
 Why?
Dendritic Cells
26
2023
135
3.650
 Why?
Cancer Vaccines
13
2020
80
2.930
 Why?
Immunotherapy
12
2019
234
1.890
 Why?
Th17 Cells
3
2020
24
1.470
 Why?
Antigens, Neoplasm
11
2019
148
1.300
 Why?
CD4-Positive T-Lymphocytes
8
2023
158
1.050
 Why?
Uterine Cervical Neoplasms
13
2011
275
0.940
 Why?
Oncogene Proteins, Viral
7
2011
52
0.790
 Why?
Neoplasm Recurrence, Local
3
2020
622
0.750
 Why?
T-Lymphocytes, Regulatory
6
2011
81
0.710
 Why?
T-Lymphocytes, Cytotoxic
12
2013
63
0.690
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
16
0.640
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
77
0.590
 Why?
Neoplasms
4
2019
1248
0.560
 Why?
CD8-Positive T-Lymphocytes
11
2023
127
0.550
 Why?
Antibodies, Monoclonal
5
2019
460
0.540
 Why?
DNA-Binding Proteins
5
2007
410
0.530
 Why?
Interleukin-17
2
2020
36
0.530
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
90
0.510
 Why?
Ascites
1
2014
28
0.440
 Why?
T-Lymphocytes
5
2017
325
0.440
 Why?
Immunologic Surveillance
2
2011
11
0.430
 Why?
Female
42
2023
27053
0.400
 Why?
Signal Transduction
3
2017
1608
0.390
 Why?
Cytokines
4
2014
602
0.390
 Why?
Carcinoma
2
2017
137
0.390
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
39
0.370
 Why?
Immunotherapy, Active
1
2011
4
0.370
 Why?
Serine Endopeptidases
3
2009
50
0.360
 Why?
Cytotoxicity, Immunologic
7
2011
57
0.360
 Why?
Humans
53
2023
50419
0.360
 Why?
Adoptive Transfer
1
2009
29
0.320
 Why?
Immunotherapy, Adoptive
3
2005
161
0.310
 Why?
Interferon-gamma
7
2020
175
0.300
 Why?
Epitopes, T-Lymphocyte
3
2008
26
0.290
 Why?
Lymphocyte Activation
3
2005
169
0.270
 Why?
Adjuvants, Immunologic
3
2011
52
0.270
 Why?
Papillomavirus Vaccines
1
2007
66
0.260
 Why?
Herpesvirus 4, Human
2
2005
37
0.260
 Why?
Immunodominant Epitopes
2
2008
8
0.260
 Why?
Cell Line, Tumor
13
2022
1393
0.260
 Why?
Animals
16
2023
13063
0.250
 Why?
Dependovirus
3
2011
102
0.230
 Why?
HLA-A2 Antigen
3
2009
11
0.220
 Why?
Cell Transformation, Viral
1
2003
25
0.210
 Why?
Cell Line, Transformed
1
2003
73
0.210
 Why?
Poxviridae Infections
1
2022
4
0.200
 Why?
Oncolytic Virotherapy
1
2022
15
0.200
 Why?
Poxviridae
1
2022
7
0.200
 Why?
Myxoma virus
1
2022
14
0.200
 Why?
Interferon Type I
1
2022
23
0.200
 Why?
Cystadenocarcinoma, Serous
5
2009
71
0.200
 Why?
Vaccination
4
2010
275
0.190
 Why?
Disease-Free Survival
2
2020
439
0.190
 Why?
Receptor, erbB-2
4
2008
73
0.190
 Why?
Papillomavirus E7 Proteins
5
2011
31
0.190
 Why?
Interleukin-10
2
2017
84
0.190
 Why?
Genes, MHC Class I
3
2008
10
0.180
 Why?
Membrane Proteins
4
2011
337
0.180
 Why?
Testis
2
2011
66
0.180
 Why?
Injections, Intradermal
1
2020
13
0.180
 Why?
Macrophages
4
2022
365
0.180
 Why?
Immunity, Humoral
1
2020
22
0.170
 Why?
Coculture Techniques
3
2014
140
0.170
 Why?
Flow Cytometry
8
2013
472
0.170
 Why?
Folate Receptor 1
1
2020
25
0.170
 Why?
Cell Movement
2
2019
244
0.170
 Why?
Carcinoma, Hepatocellular
1
2022
191
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
227
0.170
 Why?
Mice
9
2023
5659
0.170
 Why?
Carcinoma, Lewis Lung
1
2019
9
0.160
 Why?
B-Lymphocytes
5
2017
171
0.160
 Why?
Repressor Proteins
3
2011
149
0.160
 Why?
Melanoma, Experimental
1
2019
40
0.160
 Why?
Self Tolerance
1
2019
1
0.160
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.160
 Why?
Liver Neoplasms
1
2022
321
0.150
 Why?
Aged
12
2020
9738
0.150
 Why?
Transplantation, Autologous
1
2020
480
0.150
 Why?
Cells, Cultured
6
2014
1563
0.150
 Why?
Cytotoxicity Tests, Immunologic
4
2005
26
0.140
 Why?
N-Acetylglucosaminyltransferases
1
2017
16
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2017
37
0.140
 Why?
Middle Aged
16
2020
12579
0.140
 Why?
HLA Antigens
4
2006
52
0.140
 Why?
Receptors, Notch
1
2017
27
0.140
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
90
0.130
 Why?
Neoplastic Stem Cells
1
2017
97
0.130
 Why?
Carcinoma, Papillary
3
2005
47
0.130
 Why?
Adult
15
2011
13561
0.120
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.120
 Why?
Genetic Vectors
3
2011
128
0.120
 Why?
Poliovirus
2
2005
8
0.120
 Why?
Neoplasm Proteins
1
2017
320
0.120
 Why?
Clinical Trials, Phase I as Topic
1
2015
25
0.120
 Why?
Adenocarcinoma
3
2004
396
0.120
 Why?
Antigen Presentation
5
2009
25
0.120
 Why?
Galectin 3
1
2014
14
0.110
 Why?
Kallikreins
2
2005
18
0.110
 Why?
Neoplasm Invasiveness
3
2017
269
0.110
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.110
 Why?
Histocompatibility Antigens Class I
2
2005
46
0.110
 Why?
Peptide Fragments
4
2009
208
0.110
 Why?
Endometrial Neoplasms
2
2005
137
0.110
 Why?
Uterine Neoplasms
2
2005
60
0.110
 Why?
Papillomavirus Infections
3
2011
165
0.110
 Why?
Mutation
1
2019
1275
0.100
 Why?
Mice, Inbred C57BL
3
2017
1796
0.100
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
134
0.100
 Why?
Lymphocytes
1
2013
153
0.100
 Why?
Antigens, Viral
3
2007
42
0.090
 Why?
Killer Cells, Natural
4
2005
107
0.090
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.090
 Why?
rho GTP-Binding Proteins
1
2011
5
0.090
 Why?
Clonal Anergy
1
2011
13
0.090
 Why?
A Kinase Anchor Proteins
1
2011
2
0.090
 Why?
Drug Resistance, Neoplasm
5
2017
315
0.090
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.090
 Why?
Antigen-Presenting Cells
1
2011
22
0.090
 Why?
Antigens, Surface
1
2011
44
0.090
 Why?
Human papillomavirus 16
1
2011
43
0.090
 Why?
Antineoplastic Agents, Alkylating
1
2011
73
0.090
 Why?
Uterine Cervical Dysplasia
1
2011
48
0.090
 Why?
Immunity, Cellular
2
2008
68
0.090
 Why?
Cyclophosphamide
1
2011
168
0.090
 Why?
Prostate
1
2011
114
0.090
 Why?
Diphosphonates
1
2011
90
0.090
 Why?
Imidazoles
1
2011
125
0.090
 Why?
Phenotype
1
2013
736
0.080
 Why?
Gene Expression Regulation, Neoplastic
4
2011
831
0.080
 Why?
Gene Expression Profiling
2
2005
1020
0.080
 Why?
Papillomaviridae
3
2005
101
0.080
 Why?
Neoplasm Staging
3
2007
738
0.080
 Why?
Carrier Proteins
1
2011
297
0.080
 Why?
K562 Cells
2
2008
40
0.080
 Why?
Tumor Microenvironment
2
2023
221
0.080
 Why?
CA-125 Antigen
1
2008
16
0.080
 Why?
Immediate-Early Proteins
1
2008
19
0.080
 Why?
Cytomegalovirus
1
2008
28
0.080
 Why?
RNA, Messenger
4
2005
1085
0.080
 Why?
Green Fluorescent Proteins
1
2008
90
0.070
 Why?
Interleukin-4
2
2005
42
0.070
 Why?
Antibody Formation
1
2007
50
0.070
 Why?
Prostatic Neoplasms
1
2011
386
0.070
 Why?
Antibodies, Viral
1
2007
93
0.070
 Why?
Amino Acid Sequence
2
2005
575
0.070
 Why?
RNA Interference
2
2017
179
0.070
 Why?
Molecular Sequence Data
2
2005
760
0.070
 Why?
Ovary
3
2017
114
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
400
0.070
 Why?
Recombinant Proteins
1
2007
477
0.060
 Why?
Hypersensitivity, Delayed
1
2005
18
0.060
 Why?
Breast Neoplasms
3
2003
1198
0.060
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.060
 Why?
Monocytes
2
2022
130
0.060
 Why?
Cell Line
4
2010
997
0.060
 Why?
Electroporation
1
2005
17
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Gene Transfer Techniques
1
2005
41
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
568
0.060
 Why?
Interleukin-12
1
2005
29
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Immunologic Memory
1
2005
29
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Burkitt Lymphoma
1
2005
14
0.060
 Why?
Plasmodium falciparum
1
2005
18
0.060
 Why?
Malaria, Falciparum
1
2005
14
0.060
 Why?
Endemic Diseases
1
2005
22
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
30
0.060
 Why?
Gangliosides
1
2004
4
0.060
 Why?
Ascitic Fluid
1
2004
12
0.060
 Why?
Proteins
2
2005
340
0.060
 Why?
Genetic Therapy
1
2005
120
0.060
 Why?
Ovariectomy
1
2004
115
0.060
 Why?
Vaccines, Subunit
1
2004
14
0.060
 Why?
Hysterectomy
1
2004
88
0.060
 Why?
Immunization, Passive
1
2004
30
0.060
 Why?
Interleukin-6
1
2005
261
0.050
 Why?
Clinical Trials as Topic
2
2007
488
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2019
386
0.050
 Why?
Cell Differentiation
2
2004
640
0.050
 Why?
Protein Binding
1
2005
648
0.050
 Why?
Epithelial Cells
1
2005
203
0.050
 Why?
Vesiculovirus
1
2022
4
0.050
 Why?
Virus Latency
1
2003
52
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Cell Adhesion Molecules
1
2003
86
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Communication
1
2003
70
0.050
 Why?
Mammals
1
2022
50
0.050
 Why?
Nucleotidyltransferases
1
2022
14
0.050
 Why?
Disease Models, Animal
2
2022
1431
0.050
 Why?
Tumor Cells, Cultured
4
2003
453
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
210
0.050
 Why?
Disease Progression
2
2019
825
0.050
 Why?
Radiotherapy
1
2002
125
0.050
 Why?
Blood Transfusion
1
2002
123
0.050
 Why?
Rabbits
1
2022
369
0.050
 Why?
Down-Regulation
1
2003
338
0.050
 Why?
Viral Proteins
1
2022
151
0.040
 Why?
Immunohistochemistry
4
2005
955
0.040
 Why?
Carcinoma, Squamous Cell
1
2004
326
0.040
 Why?
Transcriptome
1
2022
314
0.040
 Why?
Endothelium
1
2019
37
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
61
0.040
 Why?
Gene Expression
3
2008
605
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
997
0.040
 Why?
Injections, Intraperitoneal
2
2010
59
0.040
 Why?
Tissue Banks
1
2017
9
0.040
 Why?
Antibodies, Monoclonal, Humanized
3
2004
224
0.040
 Why?
STAT3 Transcription Factor
1
2017
77
0.030
 Why?
Mice, Inbred NOD
1
2017
89
0.030
 Why?
Glycosylation
1
2017
103
0.030
 Why?
Tumor Burden
1
2017
130
0.030
 Why?
RNA, Small Interfering
1
2017
208
0.030
 Why?
Multiple Myeloma
1
2011
2990
0.030
 Why?
Protein Processing, Post-Translational
1
2017
155
0.030
 Why?
Lung Neoplasms
1
2002
597
0.030
 Why?
Kaplan-Meier Estimate
1
2017
462
0.030
 Why?
Survival Analysis
2
2010
658
0.030
 Why?
Apoptosis
2
2014
1092
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
9
0.030
 Why?
Perforin
2
2005
11
0.030
 Why?
Anti-Bacterial Agents
1
2019
751
0.030
 Why?
Neovascularization, Pathologic
1
2014
155
0.030
 Why?
Interleukin-2
2
2003
70
0.030
 Why?
Membrane Glycoproteins
2
2005
246
0.020
 Why?
Vaginal Smears
1
2011
28
0.020
 Why?
Organ Specificity
1
2011
109
0.020
 Why?
Prostate-Specific Antigen
1
2011
44
0.020
 Why?
DNA, Viral
1
2011
134
0.020
 Why?
Time Factors
2
2010
2933
0.020
 Why?
Major Histocompatibility Complex
1
2010
12
0.020
 Why?
Prognosis
2
2005
1974
0.020
 Why?
Transduction, Genetic
1
2008
45
0.020
 Why?
Fluorescent Antibody Technique
1
2008
109
0.020
 Why?
Leukocytes, Mononuclear
1
2008
118
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
T-Lymphocyte Subsets
1
2007
38
0.020
 Why?
Models, Immunological
1
2007
7
0.020
 Why?
Aged, 80 and over
2
2005
3233
0.020
 Why?
Immune Tolerance
1
2007
83
0.020
 Why?
Adolescent
2
2011
6453
0.020
 Why?
HLA-B Antigens
1
2006
8
0.020
 Why?
Clone Cells
1
2006
72
0.020
 Why?
Immunity, Innate
1
2007
104
0.020
 Why?
Male
3
2011
25866
0.020
 Why?
Combined Modality Therapy
1
2007
640
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Mice, Inbred C3H
1
2005
85
0.020
 Why?
Peptides
1
2006
220
0.010
 Why?
Protein Sorting Signals
1
2005
10
0.010
 Why?
Protein Engineering
1
2005
17
0.010
 Why?
Species Specificity
1
2005
182
0.010
 Why?
Mice, SCID
1
2005
171
0.010
 Why?
Plasmids
1
2005
159
0.010
 Why?
Histocompatibility Antigens Class II
1
2005
37
0.010
 Why?
Protein Folding
1
2005
45
0.010
 Why?
Epithelium
1
2004
66
0.010
 Why?
Endocytosis
1
2005
62
0.010
 Why?
Receptors, Cell Surface
1
2005
117
0.010
 Why?
Carboplatin
1
2004
54
0.010
 Why?
Radiotherapy, Adjuvant
1
2004
63
0.010
 Why?
Paclitaxel
1
2004
84
0.010
 Why?
Transfection
1
2005
353
0.010
 Why?
Polymerase Chain Reaction
1
2005
447
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
49
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
13
0.010
 Why?
Tumor Stem Cell Assay
1
2003
17
0.010
 Why?
Proportional Hazards Models
1
2005
416
0.010
 Why?
Keratinocytes
1
2004
73
0.010
 Why?
Cervix Uteri
1
2004
42
0.010
 Why?
Up-Regulation
1
2005
446
0.010
 Why?
Swine
1
2005
408
0.010
 Why?
Kinetics
1
2005
634
0.010
 Why?
Receptors, Interleukin-2
1
2002
6
0.010
 Why?
Lymphocyte Subsets
1
2002
14
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
49
0.010
 Why?
Cell Culture Techniques
1
2003
97
0.010
 Why?
Antigens, CD19
1
2002
28
0.010
 Why?
Leukocytes
1
2003
69
0.010
 Why?
Receptors, IgG
1
2002
23
0.010
 Why?
Cell Death
1
2003
175
0.010
 Why?
Doxorubicin
1
2004
235
0.010
 Why?
Immunophenotyping
1
2002
106
0.010
 Why?
Cisplatin
1
2004
283
0.010
 Why?
Survival Rate
1
2005
906
0.010
 Why?
Tumor Virus Infections
1
2002
47
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
44
0.010
 Why?
Young Adult
1
2011
4075
0.010
 Why?
Fatal Outcome
1
2002
197
0.010
 Why?
Cell Division
1
2002
292
0.010
 Why?
Case-Control Studies
1
2004
1152
0.010
 Why?
Prospective Studies
1
2004
2378
0.010
 Why?
Risk Factors
1
2004
3712
0.010
 Why?
Antineoplastic Agents
1
2002
1165
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (299) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department